A phase II study of metronomic chemotherapy in elderly non-fit patients (>65 years) with aggressive B-Cell lymphomas.
Latest Information Update: 07 Oct 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Etoposide (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Vinorelbine (Primary)
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma; T-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms FIL_DEVECs
- 07 Oct 2021 Planned End Date changed to 27 Mar 2020.
- 07 Oct 2021 New trial record